Literature DB >> 17541489

Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2007: 2L-Registry, Kardio-Pro, EVER, AFFECT, VTACH, ARTS II, OPTAMI, PEPCAD I, PEPCAD II, GERSHWIN, SPICE, FIX-CHF and CREDIT.

Stephan Rosenkranz1, Lars S Maier, Christoph Maack, Michael Böhm.   

Abstract

This article summarizes the results of a number of new clinical trials, registries and metaanalyses in the field of cardiovascular medicine. Key presentations made at the 73(rd) annual meeting of the German Cardiac Society, held in Mannheim, Germany, in April 2007 are reported. The data were presented by leading experts in the field with relevant positions in the trials, registries or metaanalyses. These comprehensive summaries should provide the readers with the most recent data on diagnostic and therapeutic developments in cardiovascular medicine.

Entities:  

Mesh：

Year:  2007        PMID： 17541489     DOI： 10.1007/s00392-007-0548-2

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


  19 in total

1.  [Recommendations for an extensive risk decrease for patients with coronary disease, vascular diseases and diabetes. Issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research, reviewed on behalf of the Clinical Cardiology Commission by the Prevention Project Group].

Authors:  H Gohlke; W Kübler; P Mathes; T Meinertz; G Schuler; D B Gysan; G Sauer
Journal:  Z Kardiol       Date:  2001-02

Review 2.  Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure.

Authors:  H N Sabbah; W Haddad; Y Mika; O Nass; R Aviv; V G Sharov; V Maltsev; B Felzen; A I Undrovinas; S Goldstein; N Darvish; S A Ben-Haim
Journal:  Heart Fail Rev       Date:  2001-01       Impact factor: 4.214

3.  Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

Authors:  Patrick W Serruys; Andrew T L Ong; Lex A van Herwerden; J Eduardo Sousa; Adib Jatene; Johannes J R M Bonnier; Jacques P M A Schönberger; Nigel Buller; Robert Bonser; Clemens Disco; Bianca Backx; Paul G Hugenholtz; Brian G Firth; Felix Unger
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

4.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

5.  Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.

Authors:  Gerd Assmann; Paul Cullen; Helmut Schulte
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

6.  Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol.

Authors:  C J Holubarsch; W S Colucci; T Meinertz; W Gaus; M Tendera
Journal:  Eur J Heart Fail       Date:  2000-12       Impact factor: 15.534

7.  Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently.

Authors:  R H Schwinger; M Pietsch; K Frank; K Brixius
Journal:  J Cardiovasc Pharmacol       Date:  2000-05       Impact factor: 3.105

8.  Long-term results of a three-week intensive cardiac out-patient rehabilitation program in motivated patients with low social status.

Authors:  B Bjarnason-Wehrens; D Bott; L Benesch; K O Bischoff; B Buran-Kilian; D Gysan; U Hollenstein; W Mayer-Berger; R Wilkniss; G Sauer
Journal:  Clin Res Cardiol       Date:  2006-12-14       Impact factor: 5.460

9.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

10.  Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

Authors:  Victor M G Legrand; Patrick W Serruys; Felix Unger; Ben A van Hout; Mathias C M Vrolix; Geert M P Fransen; Torsten Toftegaard Nielsen; Peter Kildeberg Paulsen; Ricardo Seabra Gomes; João M G de Queiroz e Melo; José P Marques dos Santos Neves; Wietze Lindeboom; Bianca Backx
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690
View more
  5 in total

1.  Drug-eluting balloon: Initial experience in patients with in-stent restenosis (ISR).

Authors:  A J Swamy; Anil Kumar; G Keshavamurthy; D S Chadha
Journal:  Med J Armed Forces India       Date:  2014-04-26

2.  Coronary surgery for acute coronary syndrome: which determinants of outcome remain?

Authors:  K Alexiou; U Kappert; A Staroske; D Joskowiak; M Wilbring; K Matschke; S M Tugtekin
Journal:  Clin Res Cardiol       Date:  2008-03-31       Impact factor: 5.460

3.  AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation.

Authors:  Ulrich Tebbe; Ralph Oeckinghaus; Karl-Friedrich Appel; Hubertus Heuer; Hendrik Haake; Egbert Eggers; Karlheinz Seidel; Jan Adams; Job Harenberg
Journal:  Clin Res Cardiol       Date:  2008-03-05       Impact factor: 5.460

4.  Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial.

Authors:  Sang-Don Park; Chang-Hwan Yoon; Il-Young Oh; Jung-Won Suh; Young-Suk Cho; Tae-Jin Youn; Dong-Ju Choi; In-Ho Chae
Journal:  Trials       Date:  2013-02-08       Impact factor: 2.279

Review 5.  Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2009.

Authors:  L S Maier; S H Schirmer; K Walenta; C Jacobshagen; M Böhm
Journal:  Clin Res Cardiol       Date:  2009-05-26       Impact factor: 5.460
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.